Cargando…
Anticoagulation in atrial fibrillation: the present and the future
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and associated with significant mortality and morbidity. It is a powerful predictor of future embolic stroke, such that anticoagulation is recommended in the majority of patients. For many years this has predominantly been in the...
Autores principales: | Dweck, Marc R, Shah, Anoop S V, Fox, Keith A A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738362/ https://www.ncbi.nlm.nih.gov/pubmed/24175070 http://dx.doi.org/10.1258/cvd.2012.012018 |
Ejemplares similares
-
Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014) -
Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022) -
Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022) -
The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin, Alpesh
Publicado: (2013)